Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. [electronic resource]
Producer: 20111024Description: 99-105 p. digitalISSN:- 1472-1465
- Antipsychotic Agents -- therapeutic use
- Cardiovascular Diseases -- diagnosis
- Comorbidity
- Diabetes Mellitus -- diagnosis
- Evidence-Based Medicine
- Guideline Adherence
- Humans
- Mass Screening -- methods
- Obesity -- epidemiology
- Patient Education as Topic
- Practice Guidelines as Topic
- Risk Factors
- Schizophrenia -- drug therapy
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.